Putnam Investments’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Putnam Investments’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-144,249	Closed	-$1.56M	–	1419
2016 Q2	$1.56M	Hold	144,249	–	–	﹤0.01%	995
2016 Q1	$956K	Buy	144,249 +4,249	+3%	+$38.6K	﹤0.01%	1121
2015 Q4	$2.53M	Hold	140,000	–	–	0.01%	910
2015 Q3	$1.54M	Hold	140,000	–	–	﹤0.01%	1061
2015 Q2	$2.02M	Hold	140,000	–	–	﹤0.01%	1064
2015 Q1	$1.64M	Buy	+140,000	New	+$1.89M	﹤0.01%	1096

Other funds holding VTAE

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments's VTAE Position: Q3 2016 in Review

Putnam Investments sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 144,249 shares — an estimated $1.56M sold.

Putnam Investments first reported a position in VTAE in Q1 2015 and held it in 6 quarters. The position peaked at $2.53M in Q4 2015. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

Putnam Investments reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Putnam Investments sold 144,249 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $1.56M.
Putnam Investments first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 6 quarters.
Putnam Investments's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.53M in Q4 2015.
98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.